Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Mammary Glands01:12

The Mammary Glands

3.2K
The female breast is a hemispheric projection of variable size positioned anterior to the pectoralis major and serratus anterior muscles. A fascia layer composed of dense, irregular connective tissue connects it to these muscles.
Each breast features a pigmented projection known as the nipple, through which milk emerges via closely spaced openings of ducts, referred to as lactiferous ducts. Surrounding the nipple is a circular pigmented area of skin named the areola, which appears rough due to...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persistent Pyelonephritis and Renal Abscess due to <i>Mycoplasma hominis</i> in an Immunocompromised Patient: A Case Report.

Case reports in infectious diseases·2026
Same author

High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Glofitamab plus gemcitabine and oxaliplatin for relapsed/refractory DLBCL: 3-year follow-up of STARGLO.

Blood advances·2026
Same author

Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study.

HemaSphere·2026
Same author

Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial.

Lancet (London, England)·2026
Same author

Reduced-Dose Total Skin Electron Beam Radiation Therapy in Mycosis Fungoides and Sézary Syndrome: Systematic Review and Meta-Analysis.

International journal of radiation oncology, biology, physics·2026
Same journal

Neoadjuvant and adjuvant therapy in uveal melanoma: toward systemic control of a systemic disease.

Cancer treatment reviews·2026
Same journal

Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective.

Cancer treatment reviews·2026
Same journal

Treatment of breast cancer brain metastases in the era of novel drugs.

Cancer treatment reviews·2026
Same journal

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Cancer treatment reviews·2026
Same journal

Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer.

Cancer treatment reviews·2026
Same journal

Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreatic ductal adenocarcinoma: a systematic review.

Cancer treatment reviews·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on: April 3, 2026

420

Primary breast lymphoma.

Chan Y Cheah1, Belinda A Campbell2, John F Seymour1

  • 1Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia; University of Melbourne, Parkville, Melbourne, Victoria, Australia.

Cancer Treatment Reviews
|June 24, 2014
PubMed
Summary
This summary is machine-generated.

Primary breast lymphoma, a rare extranodal lymphoma, most commonly presents as diffuse large B-cell lymphoma. This review details its clinical features, diagnosis, risk factors, and treatment, including chemotherapy and radiotherapy.

Keywords:
Breast neoplasmsExtranodal lymphomaNon-Hodgkin lymphomaPrimary breast lymphomaReview article

More Related Videos

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

5.8K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

10.6K

Related Experiment Videos

Last Updated: Apr 27, 2026

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on: April 3, 2026

420
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

5.8K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

10.6K

Area of Science:

  • Oncology
  • Hematology
  • Pathology

Background:

  • Primary breast lymphoma is a rare extranodal lymphoma originating in the breast.
  • Diffuse large B-cell lymphoma (DLBCL) is the most frequent histologic subtype.
  • It is defined by breast lesions with or without regional nodal involvement, excluding other sites.

Purpose of the Study:

  • To provide a comprehensive review of primary breast diffuse large B-cell lymphoma.
  • To detail clinical features, diagnosis, staging, pathogenesis, risk factors, and therapy.
  • To discuss treatment modalities including chemotherapy, radiotherapy, and central nervous system prophylaxis.

Main Methods:

  • Literature review focusing on primary breast lymphoma, particularly DLBCL.
  • Analysis of clinical presentation, diagnostic criteria, and staging procedures.
  • Evaluation of therapeutic strategies, including chemotherapy regimens and radiotherapy indications.

Main Results:

  • Diffuse large B-cell lymphoma is the predominant subtype of primary breast lymphoma.
  • Key treatment considerations include chemotherapy cycles, radiotherapy, and CNS prophylaxis.
  • Other rare subtypes like marginal zone, follicular, Burkitt, and ALCL are briefly reviewed.

Conclusions:

  • A suggested treatment approach for primary breast lymphoma is outlined.
  • Future research directions in understanding and managing this rare condition are identified.
  • Effective management requires a multidisciplinary approach considering diverse therapeutic options.